Novavax (NVAX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.52 +5.78%
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $6.42 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
